Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Oct 03, 2020 3:10pm
276 Views
Post# 31663390

RE:RE:QuestCap Mgmt. & Advisors should be able to get HC Approval

RE:RE:QuestCap Mgmt. & Advisors should be able to get HC Approval Made in China mean nothing. All anyone in the stock market care about is approved by FDA as (Emergency Use Authorization) approved by Health Canada then Revenue and Profit Margin.
   
Covid-19 test offered by QuestCap show really good accuracy 98.8% so compare that to anyone else. The clinical performance was evaluated by NCI’s Frederick National Laboratory and it reported a combined IgG/IgM sensitivity and specificity of 100% and 98.8%, respectively. You can compare all these covid-19 rapid test approved by FDA as (Emergency Use Authorization) and see LYHER Novel Coronavirus and see this test stack very well against everyone else https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/eua-authorized-serology-test-performance
 
  • Once these 165 testing centres pods launched; Does anyone really think people waiting in the lineup to get tested will be asking to show us made in country stamp.
  • Once these QuestCubes start generating millions $$$ in revenue per month: Does anyone really think investors not going to buy QSC shares because they are using Made in China tests.
 
Why people are not taking about QuestCap
 
Because Questcap management does not hire a proper PR firm to distribute press release all over the world. I think they can correct this easily. All they need to do is once they are ready to launch these testing centres. They need to hold a press conference inviting all top business reporters. Then explain where these pods are being launch, how many and which states, how many they are ordering more of these pods, and how much these tests cost compare to competition.
 
This will work for both promoting these testing centres as local media should pickup these feeds and it will also create awareness about QSC stock. We the current shareholder are not interested in making pennies taking .5-.10-.15-.25 cents in profit. QuestCap stock should be able to multiply like 5x-10x-25x with possible recurring revenue of $44 USD per month then add covid-19 tests being sold in Columbia S.A. and then all other investments like Sunnybrook Hospital, Sinai Foundation , Amino Therapeutics, Glenco Medical and PCL Korea approval in Brazil. I also think once these 165 pods are delivered, QuestCap will add another order for more Cubes as they talk about 100’s not just 165. These Cubes are cheap to buy, easy to move around to different location anywhere in USA or Canada. Once they don’t need these Cubes in few years, they can be resold as backyard shed or storage room for the Farm Lol..


Suggardaddy68 wrote:
its a made in China product thats gotta be a real issue here nobody is talking about


<< Previous
Bullboard Posts
Next >>